153 related articles for article (PubMed ID: 10720582)
1. Evaluation of the aldosterone synthase (CYP11B2) gene polymorphism in patients with myocardial infarction.
Hengstenberg C; Holmer SR; Mayer B; Löwel H; Engel S; Hense HW; Riegger GA; Schunkert H
Hypertension; 2000 Mar; 35(3):704-9. PubMed ID: 10720582
[TBL] [Abstract][Full Text] [Related]
2. Association of aldosterone synthase CYP11B2 (-344C/T) gene polymorphism with essential hypertension and left ventricular hypertrophy in the Egyptian population.
Abdel Ghafar MT
Clin Exp Hypertens; 2019; 41(8):779-786. PubMed ID: 30561227
[No Abstract] [Full Text] [Related]
3. Analysis of promoter region polymorphism in the aldosterone synthase gene (CYP11B2) as a risk factor for myocardial infarction.
Patel S; Steeds R; Channer K; Samani NJ
Am J Hypertens; 2000 Feb; 13(2):134-9. PubMed ID: 10701812
[TBL] [Abstract][Full Text] [Related]
4. Aldosterone synthase gene (CYP11B2) C-344T polymorphism in Caucasians from the Berlin Salt-Sensitivity Trial (BeSST).
Brand E; Schorr U; Ringel J; Beige J; Distler A; Sharma AM
J Hypertens; 1999 Nov; 17(11):1563-7. PubMed ID: 10608469
[TBL] [Abstract][Full Text] [Related]
5. Lack of association between a polymorphism of the aldosterone synthase gene and left ventricular structure.
Schunkert H; Hengstenberg C; Holmer SR; Broeckel U; Luchner A; Muscholl MW; Kürzinger S; Döring A; Hense HW; Riegger GA
Circulation; 1999 May; 99(17):2255-60. PubMed ID: 10226090
[TBL] [Abstract][Full Text] [Related]
6. Joint effects of an aldosterone synthase (CYP11B2) gene polymorphism and classic risk factors on risk of myocardial infarction.
Hautanen A; Toivanen P; Mänttäri M; Tenkanen L; Kupari M; Manninen V; Kayes KM; Rosenfeld S; White PC
Circulation; 1999 Nov; 100(22):2213-8. PubMed ID: 10577993
[TBL] [Abstract][Full Text] [Related]
7. Aldosterone synthase -344C/T and angiotensin-converting enzyme I/D polymorphisms in Turkish hypertensive patients with normal coronary arteries.
Olcay A; Nisanci Y; Ekmekci CG; Umman B; Bugra Z; Sezer M; Acar RD; Ozbek U
Acta Cardiol; 2006 Feb; 61(1):29-34. PubMed ID: 16485730
[TBL] [Abstract][Full Text] [Related]
8. Human aldosterone synthase gene polymorphism promotes miRNA binding and regulates gene expression.
Maharjan S; Mopidevi B; Kaw MK; Puri N; Kumar A
Physiol Genomics; 2014 Dec; 46(24):860-5. PubMed ID: 25351194
[TBL] [Abstract][Full Text] [Related]
9. [Specifics of distribution of polymorphic markers of the renin-angiotensin-system genes, relation to ventricular hypertrophy in patients with essential hypertension of Uzbek nationality].
Khamidullaeva GA; Eliseeva MR; Srozhiddinova NZ; Abdullaeva GZh
Kardiologiia; 2007; 47(4):54-8. PubMed ID: 18260840
[TBL] [Abstract][Full Text] [Related]
10. Association between aldosterone synthase (CYP11B2) polymorphism and left ventricular mass in human essential hypertension.
Stella P; Bigatti G; Tizzoni L; Barlassina C; Lanzani C; Bianchi G; Cusi D
J Am Coll Cardiol; 2004 Jan; 43(2):265-70. PubMed ID: 14736447
[TBL] [Abstract][Full Text] [Related]
11. Haplotype association and synergistic effect of human aldosterone synthase (CYP11B2) gene polymorphisms causing susceptibility to essential hypertension in Indian patients.
Vamsi UM; Swapna N; Padma G; Vishnupriya S; Padma T
Clin Exp Hypertens; 2016; 38(8):659-665. PubMed ID: 27935319
[TBL] [Abstract][Full Text] [Related]
12. Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function.
Kupari M; Hautanen A; Lankinen L; Koskinen P; Virolainen J; Nikkila H; White PC
Circulation; 1998 Feb; 97(6):569-75. PubMed ID: 9494027
[TBL] [Abstract][Full Text] [Related]
13. [Genetic factors in myocardial infarction--Results from a candidate gene and a genome-wide approach between beta blockers].
Hengstenberg C; Bröckel U; Holmer S; Mayer B; Fischer M; Baessler A; Erdmann J; Lieb W; Löwel H; Riegger G; Schunkert H
Herz; 2002 Nov; 27(7):649-61. PubMed ID: 12439636
[TBL] [Abstract][Full Text] [Related]
14. Aldosterone synthase gene (CYP11B2) C-344T polymorphism, plasma aldosterone, renin activity and blood pressure in a multi-ethnic population.
Barbato A; Russo P; Siani A; Folkerd EJ; Miller MA; Venezia A; Grimaldi C; Strazzullo P; Cappuccio FP
J Hypertens; 2004 Oct; 22(10):1895-901. PubMed ID: 15361760
[TBL] [Abstract][Full Text] [Related]
15. The cytochrome 11B2 aldosterone synthase gene rs1799998 single nucleotide polymorphism determines elevated aldosterone, higher blood pressure, and reduced glomerular filtration, especially in diabetic female patients.
Sydorchuk L; Dzhuryak V; Sydorchuk A; Levytska S; Petrynych V; Knut R; Kshanovska A; Iftoda O; Tkachuk O; Kyfiak P; Popovich A; Khomko O; Sydorchuk R
Endocr Regul; 2020 Jul; 54(3):217-226. PubMed ID: 32857720
[TBL] [Abstract][Full Text] [Related]
16. Lys(173)Arg and -344T/C variants of CYP11B2 in Japanese patients with low-renin hypertension.
Komiya I; Yamada T; Takara M; Asawa T; Shimabukuro M; Nishimori T; Takasu N
Hypertension; 2000 Mar; 35(3):699-703. PubMed ID: 10720581
[TBL] [Abstract][Full Text] [Related]
17. Correlation between left ventricular mass and urinary sodium excretion in specific genotypes of CYP11B2.
Isaji M; Mune T; Takada N; Yamamoto Y; Suwa T; Morita H; Takeda J; White PC
J Hypertens; 2005 Jun; 23(6):1149-57. PubMed ID: 15894890
[TBL] [Abstract][Full Text] [Related]
18. Association of the -344T/C aldosterone synthase gene variant with essential hypertension.
Hlubocká Z; Jáchymová M; Heller S; Umnerová V; Danzig V; Lánská V; Horký K; Linhart A
Physiol Res; 2009; 58(6):785-792. PubMed ID: 19093739
[TBL] [Abstract][Full Text] [Related]
19. [Effect of CYP11B2 gene -344T/C polymorphism on renin-angiotensin-aldosterone system activity and blood pressure response to hydrochlorothiazide].
Li Y; Yang P; Wu SL; Yuan JX; Wu Y; Zhao DD; Xu S; Zhao LP; Sun MJ; Chu LM; Lu DS
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Feb; 29(1):68-71. PubMed ID: 22311496
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of the aldosterone synthase gene polymorphism C-344-T to predict cardiac remodeling in African-Americans versus non-African-Americans with chronic systolic heart failure.
Biolo A; Chao T; Duhaney TA; Kotlyar E; Allensworth-Davies D; Loscalzo J; Sam F
Am J Cardiol; 2007 Jul; 100(2):285-90. PubMed ID: 17631084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
